Closed-loop insulin delivery – what lies between where we are and where we are going?

Closed-loop insulin delivery in individuals with diabetes can potentially lead to near-normal glucose profiles. To this end, existing subcutaneous glucose sensors and external insulin pumps can be linked with an insulin delivery algorithm to create a completely automated closed-loop system. This paper reviews current research into the development of such a system, with particular emphasis on creating a system emulating the physiological properties of the β-cell. Issues related to using subcutaneous interstitial fluid for glucose -sensing and insulin delivery are reviewed. Criteria for optimising the system are discussed using historical data. Existing strategies for open-loop pump therapy are presented with the objective of defining a path to advance from the existing physician/patient determined insulin therapy to a completely automated system.

[1]  A. Cherrington,et al.  Direct and indirect effects of insulin on glucose uptake and storage by the liver. , 2002, Diabetes.

[2]  Edwin Liu,et al.  Type 1 diabetes: recent developments , 2004, BMJ : British Medical Journal.

[3]  A. Baron,et al.  Hemodynamic actions of insulin. , 1994, The American journal of physiology.

[4]  R. Bergman,et al.  Accurate Assessment of β-Cell Function: The Hyperbolic Correction , 2002 .

[5]  R. Bergman,et al.  Modeling of insulin action in vivo. , 1992, Annual review of physiology.

[6]  Claudio Cobelli,et al.  Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method. , 2004, American journal of physiology. Endocrinology and metabolism.

[7]  R. Bonnecaze,et al.  Measurement and modeling of the transient difference between blood and subcutaneous glucose concentrations in the rat after injection of insulin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[8]  H. Landahl,et al.  [Further studies on the dynamic aspects of insulin release in vitro with evidence for a two-compartmental storage system]. , 1969, Acta diabetologica latina.

[9]  R N Bergman,et al.  Assessment of insulin sensitivity in vivo. , 1985, Endocrine reviews.

[10]  Andrea Tura,et al.  Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. , 2002, Diabetes.

[11]  G. S. Wilson,et al.  Interstitial glucose concentration and glycemia: implications for continuous subcutaneous glucose monitoring. , 2000, American journal of physiology. Endocrinology and metabolism.

[12]  R. Bergman,et al.  Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function , 1993, Diabetes.

[13]  S. Bonner-Weir,et al.  Assessment of human islet preparations to be used for islet expansion, survival, or transplant. , 2004, Diabetes technology & therapeutics.

[14]  J. Mastrototaro,et al.  Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. , 2000, Diabetes technology & therapeutics.

[15]  G. Steil,et al.  Evaluation of insulin sensitivity and beta-cell function indexes obtained from minimal model analysis of a meal tolerance test. , 2004, Diabetes.

[16]  J. Chiasson,et al.  Glucose turnover and gluconeogenesis during pregnancy in women with and without insulin-dependent diabetes mellitus. , 1997, Clinical and investigative medicine. Medecine clinique et experimentale.

[17]  R. Potts,et al.  Physiological differences between interstitial glucose and blood glucose measured in human subjects. , 2003, Diabetes care.

[18]  David Kerr,et al.  Performance of a continuous glucose monitoring system during controlled hypoglycaemia in healthy volunteers. , 2002, Diabetes technology & therapeutics.

[19]  A. Secchi,et al.  Long-term survival after kidney and kidney-pancreas transplantation in diabetic patients. , 2004, Transplantation Proceedings.

[20]  R. Bergman,et al.  Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. , 1996, The Journal of clinical investigation.

[21]  R. Bergman,et al.  Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. , 1990, The American journal of physiology.

[22]  R. Bergman.  New concepts in extracellular signaling for insulin action: the single gateway hypothesis. , 1997, Recent progress in hormone research.

[23]  G. Steil,et al.  Determination of plasma glucose during rapid glucose excursions with a subcutaneous glucose sensor. , 2003, Diabetes technology & therapeutics.

[24]  C Cobelli,et al.  Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. , 2001, Diabetes.

[25]  Eldon D Lehmann.  British Diabetic Association review of the AIDA v4 diabetes software simulator program. , 2004, Diabetes technology & therapeutics.

[26]  R S Parker,et al.  The intravenous route to blood glucose control. , 2001, IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society.

[27]  John J Mastrototaro,et al.  Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring. , 1999, American journal of physiology. Endocrinology and metabolism.

[28]  N. Fineberg,et al.  A randomized, controlled study of insulin pump therapy in diabetic preschoolers. , 2004, The Journal of pediatrics.

[29]  C. Chia,et al.  Glucose sensors: toward closed loop insulin delivery. , 2004, Endocrinology and metabolism clinics of North America.

[30]  Norman Fleischer,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. , 1993 .

[31]  Roman Hovorka,et al.  Pancreatic β-Cell Responsiveness during Meal Tolerance Test: Model Assessment in Normal Subjects and Subjects with Newly Diagnosed Noninsulin-Dependent Diabetes Mellitus1 , 1998 .

[32]  G Reach,et al.  Use of a subcutaneous glucose sensor to detect decreases in glucose concentration prior to observation in blood. , 1996, Analytical chemistry.

[33]  John Thomas Sorensen,et al.  A physiologic model of glucose metabolism in man and its use to design and assess improved insulin therapies for diabetes , 1985 .

[34]  Claudio Cobelli,et al.  Insulin release in impaired glucose tolerance: oral minimal model predicts normal sensitivity to glucose but defective response times. , 2002, Diabetes.

[35]  G M Steil,et al.  Role of portal insulin delivery in the disappearance of intravenous glucose and assessment of insulin sensitivity. , 1998, Diabetes.

[36]  Andrea Mari,et al.  Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects. , 2002, American journal of physiology. Endocrinology and metabolism.

[37]  N. Barshes,et al.  Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a first-year review. , 2004, Transplantation proceedings.

[38]  Erol Cerasi,et al.  Modeling phasic insulin release: immediate and time-dependent effects of glucose. , 2002, Diabetes.

[39]  S. Efrat.  Regulation of insulin secretion: insights from engineered beta-cell lines. , 2004, Annals of the New York Academy of Sciences.

[40]  G. Grodsky,et al.  Paper Chromatography of Insulin , 1956, Nature.

[41]  E. Ferrannini,et al.  A model for glucose control of insulin secretion during 24 h of free living. , 2001, Diabetes.

[42]  G. Steil,et al.  Modeling beta-cell insulin secretion--implications for closed-loop glucose homeostasis. , 2003, Diabetes technology & therapeutics.

[43]  R. Bellazzi,et al.  The subcutaneous route to insulin-dependent diabetes therapy. , 2001, IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society.

[44]  Claudio Cobelli,et al.  Use of a novel triple-tracer approach to assess postprandial glucose metabolism. , 2003, American journal of physiology. Endocrinology and metabolism.

[45]  G M Steil,et al.  Modeling insulin action for development of a closed-loop artificial pancreas. , 2005, Diabetes technology & therapeutics.

[46]  W. Tamborlane,et al.  Insulin pump therapy in the 21st century , 2002, Postgraduate medicine.

[47]  D W Neal,et al.  Basal hepatic glucose production is regulated by the portal vein insulin concentration. , 1998, Diabetes.

[48]  S. Gitelman,et al.  Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1 diabetes mellitus. , 2002, The Journal of pediatrics.

[49]  O. McGuinness,et al.  Physiological consequences of phasic insulin release in the normal animal. , 2002, Diabetes.

[50]  E. Cerasi,et al.  A Mathematical Model for the Glucose Induced Insulin Release in Man , 1974, European journal of clinical investigation.

[51]  D. O'leary,et al.  Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. , 2003, The New England journal of medicine.

[52]  Claudio Cobelli,et al.  Oral Glucose Tolerance Test Minimal Model Indexes of β-Cell Function and Insulin Sensitivity , 2001 .

[53]  S. Mudaliar,et al.  Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. , 1999, Diabetes care.

[54]  R. Bergman,et al.  Free Fatty Acid as a Link in the Regulation of Hepatic Glucose Output by Peripheral Insulin , 1995, Diabetes.

[55]  G M Steil,et al.  Dynamics of Glucose Production and Uptake Are More Closely Related to Insulin in Hindlimb Lymph Than in Thoracic Duct Lymph , 1994, Diabetes.

[56]  S. Efrat.  Regulation of Insulin Secretion: Insights from Engineered β‐cell Lines , 2004 .

[57]  P. Abel,et al.  Automated feedback control of subcutaneous glucose concentration in diabetic dogs , 2004, Diabetologia.

[58]  E J Freyse,et al.  Artificial connection between glucose sensing and insulin delivery: implications of peritoneal administration. , 1992, Artificial organs.

[59]  R. Bergman,et al.  Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. , 1981, The Journal of clinical investigation.

[60]  F Tosi,et al.  Assessment of β‐cell function during the oral glucose tolerance test by a minimal model of insulin secretion , 2001, European journal of clinical investigation.

[61]  G. Korbutt,et al.  Harnessing the Immunomodulatory Properties of Sertoli Cells to Enable Xenotransplantation in Type I Diabetes , 2003, Immunological investigations.

[62]  W. Tamborlane,et al.  A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. , 2004, Diabetes care.

[63]  I. Hirsch,et al.  Assessment of therapy with continuous subcutaneous insulin infusion in an academic diabetes clinic. , 2002, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[64]  G. Korbutt,et al.  Stem cell-based approaches to solving the problem of tissue supply for islet transplantation in type 1 diabetes. , 2004, The international journal of biochemistry & cell biology.

[65]  R. Bergman,et al.  Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia. , 1997, The Journal of clinical investigation.

[66]  D. Harlan,et al.  Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. , 2004, The Journal of clinical investigation.

[67]  C. Saudek,et al.  Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. , 2003, Diabetes.

[68]  G. Steil,et al.  Closed-loop insulin delivery-the path to physiological glucose control. , 2004, Advanced drug delivery reviews.

[69]  G M Steil,et al.  Can interstitial glucose assessment replace blood glucose measurements? , 2000, Diabetes technology & therapeutics.

[70]  F. Sternberg,et al.  Does fall in tissue glucose precede fall in blood glucose? , 1996, Diabetologia.

[71]  Claudio Cobelli,et al.  Models of subcutaneous insulin kinetics. A critical review , 2000, Comput. Methods Programs Biomed..

[72]  R S Parker,et al.  Control-relevant modeling in drug delivery. , 2001, Advanced drug delivery reviews.

[73]  R. Bergman,et al.  Biphasic insulin secretion during intravenous glucose tolerance test promotes optimal interstitial insulin profile. , 1998, Diabetes.

[74]  R. Trevisan,et al.  Effect of continuous subcutaneous insulin infusion vs multiple daily insulin injection with glargine as basal insulin: an open parallel long-term study. , 2004, Diabetes, nutrition & metabolism.

[75]  K. Rebrin,et al.  Increased Urea Synthesis in Insulin-Dependent Diabetic Dogs Maintained Normoglycemic: Effect of Portal Insulin Administration and Food Protein Content , 1996, Diabetes.